177 Lu‐Loaded Composite Microspheres with Micro/Nano‐Structure for Radioembolization Therapy of Hepatocellular Carcinoma
Small · 2026-07 · 22 (38)
DOI: 10.1002/smll.73838 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, online erschienen am 21.05.2026. Verfasst von Ling-Yun Guo und 11 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemical Engineering, Sichuan University, Chengdu, China. Hauptthemen laut MEDLINE: Microspheres, Liver Neoplasms, Carcinoma, Hepatocellular, Radioembolization, Therapeutic. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, Sichuan Provincial Natural Science Foundation.
Abstract (Originalsprache)
Transarterial radioembolization (TARE) is a well‐established therapy for hepatocellular carcinoma. However, existing radioembolic microspheres face limitations, such as single size selection, poor elasticity, lack of theranostic integration, and insufficient stability, which limit their clinical application in TARE. In this study, polydopamine@chitosan (PDA@CS) microspheres featuring a micro‐nano composite structure are fabricated by a facile microfluidic method. These microspheres stably chelate Lu 3+ (forming 177 Lu‐PDA@CS microspheres) through catechol‐metal coordination via the phenolic hydroxyl groups of PDA nanoparticles (PDA NPs). The compact structure of the microspheres with uniformly incorporated PDA NPs ensures radioactive stability through dual retention mechanisms: chemical retention via phenolic hydroxyl groups and physical retention by microsphere matrix. These microspheres exhibit uniform and precisely tunable sizes, good biocompatibility, appropriate elasticity, structural stability, and integrated theranostic capabilities. Key properties of PDA@CS microspheres, including morphology, elasticity, loading capacity and binding stability of Lu 3+ , can be regulated by adjusting the PDA NPs concentration in the internal fluid phase. In vivo TARE studies in rat models demonstrate that 177 Lu‐PDA@CS microspheres not only retain well within the hepatic artery, but also effectively inhibit tumor growth and metastasis while maintaining excellent biosafety. The proposed radioembolic microspheres show significant potential as an innovative radioembolic agent for primary liver cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Chemical Engineering, Sichuan University, Chengdu, China.
- Regenerative Medicine Research Center, West China Hospital, Sichuan University, Chengdu, China.
- Chongqing Institute for Food and Drug Control, Chongqing, China.
- Department of Nuclear Medicine, West China Hospital, Sichuan University, Chengdu, China.
ORCID-Profile: Zhuang Liu, Rui Xie, Liang-Yin Chu
Förderung
- National Natural Science Foundation of China
- Sichuan Provincial Natural Science Foundation
Zitieren
APA
Guo, L. Y., Yang, Q. S., Jiang, Q. R., Li, Y., Zhou, X. L., Wang, W., Liu, Z., Xie, R., Pan, D. W., Zhang, W. J., Ju, X. J., & Chu, L. Y. (2026). 177 Lu‐Loaded Composite Microspheres with Micro/Nano‐Structure for Radioembolization Therapy of Hepatocellular Carcinoma. Small, 22(38). https://doi.org/10.1002/smll.73838
Vancouver
Guo LY, Yang QS, Jiang QR, Li Y, Zhou XL, Wang W, et al. 177 Lu‐Loaded Composite Microspheres with Micro/Nano‐Structure for Radioembolization Therapy of Hepatocellular Carcinoma. Small. 2026;22(38). doi:10.1002/smll.73838
BibTeX
@article{Guo2026,
author = {Guo, Ling-Yun and Yang, Qing-Shan and Jiang, Qing-Rong and Li, Yao and Zhou, Xing-Long and Wang, Wei and Liu, Zhuang and Xie, Rui and Pan, Da-Wei and Zhang, Wen-Jie and Ju, Xiao-Jie and Chu, Liang-Yin},
title = {177 Lu‐Loaded Composite Microspheres with Micro/Nano‐Structure for Radioembolization Therapy of Hepatocellular Carcinoma},
journal = {Small},
year = {2026},
volume = {22},
number = {38},
doi = {10.1002/smll.73838}
}
EUVIMED